Search Results

Results 11 - 20 of 24 for Emily Moskal. (0.73 seconds)
  • Forum rallies DEI agents for change

    At the 2023 Stanford Medicine Diversity and Inclusion Forum, speakers emphasized communication that destigmatizes the patient, empowers frontline workers and supports non-English speaking patients.

  • Agent Orange researcher dies

    James Whitlock, MD, a professor emeritus of molecular pharmacology (now chemical and systems biology), who discovered the negative effects of dioxin on the human body, died at home.

  • Osteoarthritis linked to allergic inflammation

    A connection found between asthma, eczema and osteoarthritis indicates that drugs to treat allergic conditions could be used in future studies aimed at slowing the progression of osteoarthritis.

  • Cyclotron director dies at 43

    The director of the Stanford Medicine cyclotron and radiochemistry facility died on Jan. 25. He created novel radiotracers for clinical and research use.

  • Nobelist Paul Berg dies

    Credited with sparking the field of genetic engineering, Stanford Medicine biochemist Paul Berg shared the 1980 Nobel Prize in chemistry for creating the first recombinant DNA molecule.

  • Celiac expert Gary Gray dies at 89

    Gastroenterologist Gary Gray, part of Stanford Medicine for nearly 50 years, helped find the molecular cause of celiac disease and a potential treatment.

  • An evening to celebrate queer joy

    An Evening of Queer Joy, formerly known as the LGBTQ+ Forum, showcases the spectrum of emotions experienced by queer people.

  • Predicting immunity from vaccination

    A gene signature seen in antibody-producing cells in the blood of vaccinated study participants could expedite vaccine development.

  • New biomedical physics doctoral program

    A new PhD program, hosted by the departments of radiology and radiation oncology, trains students in technologies used for therapy and diagnostics.

  • Hodgkin lymphoma pioneer Rosenberg dies

    Rosenberg combined radiation and chemotherapy to treat Hodgkin lymphoma, revolutionizing cancer care. He taught at Stanford Medicine for more than 50 years.